Related Experiment Video

Updated: Dec 27, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.4K

String of successful trials in SLE: have we cracked the code?

Ronald van Vollenhoven1,2

  • 1Amsterdam University Medical Center, Amsterdam, The Netherlands.

Lupus Science & Medicine
|February 26, 2020
PubMed
Summary

No abstract available in PubMed .

Keywords:
disease activitysystemic lupus erythematosustreatment

More Related Videos

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

723
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K

Related Experiment Videos

Last Updated: Dec 27, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.4K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

723
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

154
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
154

Articles linked to this work by shared authors, journal, and citation graph.

Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.

Journal of internal medicine·2026

Lupus trials and tribulations: are outcome measures the problem?

EULAR rheumatology open·2026

Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.

RMD open·2026

The EULAR Research Center-5 years young and going strong.

EULAR rheumatology open·2026

Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.

Journal of internal medicine·2026

Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.

The Lancet. Rheumatology·2026

CD163: a potential biomarker for lupus nephritis activity.

Lupus science & medicine·2026

Diagnostic value of cerebrospinal fluid antisuprabasin antibody in neuropsychiatric systemic lupus erythematosus.

Lupus science & medicine·2026

Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden.

Lupus science & medicine·2026

High disease activity persists in adults with childhood-onset lupus.

Lupus science & medicine·2026

Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritis.

Lupus science & medicine·2026

Role of repeat kidney biopsy after 6 months of treatment in proliferative lupus nephritis.

Lupus science & medicine·2026

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

Cancer·2026

[Associated factors of difficult-to-treat spondyloarthritis].

La Tunisie medicale·2026

MRI-defined sacroiliitis and spinal inflammation in chronic back pain: real-world patterns in axial spondyloarthritis and axial psoriatic arthritis.

Rheumatology advances in practice·2026

Advanced arthroscopic management of diffuse knee synovial chondromatosis with large tricompartmental nodules using trans-notch visualization and a safe posteromedial portal.

International journal of surgery case reports·2026

Evaluating the access process for patients transitioning from intravenous to subcutaneous biologic administration for inflammatory bowel disease.

Crohn's & colitis 360·2026

Utility of Synovial Alpha Defensin Lateral Flow Test in Diagnosing Septic Arthritis in Native Knees.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us